275 related articles for article (PubMed ID: 3513004)
1. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
Hughes MF; Kadry AR; Gairola CG; Flesher JW
Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver.
Forti GC; Trieff NM
Teratog Carcinog Mutagen; 1980; 1(3):269-82. PubMed ID: 6119817
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity and in vivo disposition of biliary metabolites of benzo(a)pyrene.
Chipman JK; Millburn P; Brooks TM
Toxicol Lett; 1983 Jul; 17(3-4):233-40. PubMed ID: 6312638
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-mediated mutagenicity of mononitrobenzo[a]pyrenes in Salmonella typhimurium strains.
Hass BS; Heflich RH; Chou MW; White GL; Fu PP; Casciano DA
Mutat Res; 1986; 171(2-3):123-9. PubMed ID: 3528834
[TBL] [Abstract][Full Text] [Related]
6. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
[TBL] [Abstract][Full Text] [Related]
8. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of benzo(a)pyrenyl-1-sulfate in the Ames test.
Irwin SE; Kwei GY; Blackburn GR; Thurman R; Kauffman FC
Environ Mol Mutagen; 1992; 19(3):253-8. PubMed ID: 1572348
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene.
Devanesan PD; Cremonesi P; Nunnally JE; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1990; 3(6):580-6. PubMed ID: 2103330
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of benzo(a)pyrene-3-O-glucuronide, a biliary metabolite of benzo(a)pyrene.
Chipman JK; Millburn P; Brooks TM
Toxicol Lett; 1983 Jul; 17(3-4):361-2. PubMed ID: 6312639
[No Abstract] [Full Text] [Related]
12. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
[TBL] [Abstract][Full Text] [Related]
13. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
14. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
15. Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites.
Lynn RK; Garvie-Gould CT; Milam DF; Scott KF; Eastman CL; Ilias AM; Rodgers RM
Toxicol Appl Pharmacol; 1984 Jan; 72(1):1-14. PubMed ID: 6710475
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
[TBL] [Abstract][Full Text] [Related]
17. Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
Szyba K; Lange A
Environ Health Perspect; 1983 Sep; 51():337-41. PubMed ID: 6315376
[TBL] [Abstract][Full Text] [Related]
18. The metabolic activation of benzo(a)pyrene and 9-hydroxybenzo(a)pyrene by liver microsomal fractions.
Lubet RA; Capdevila J; Prough RA
Int J Cancer; 1979 Mar; 23(3):353-7. PubMed ID: 374283
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
[TBL] [Abstract][Full Text] [Related]
20. Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
Platt KL; Degenhardt C; Grupe S; Frank H; Seidel A
Chem Res Toxicol; 2002 Mar; 15(3):332-42. PubMed ID: 11896680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
